Brain RNA profiling highlights multiple disease pathways in persons with HIV-associated neurocognitive disorder
- PMID: 39820157
- PMCID: PMC11908890
- DOI: 10.1097/QAD.0000000000004116
Brain RNA profiling highlights multiple disease pathways in persons with HIV-associated neurocognitive disorder
Abstract
Objective: To discover microRNA (miRNA)-RNA transcript interactions dysregulated in brains from persons with HIV-associated neurocognitive disorder (HAND), we investigated RNA expression using machine learning tools.
Design: Brain-derived host RNA transcript and miRNA expression was examined from persons with or without HAND using bioinformatics platforms.
Methods: By combining next generation sequencing, droplet digital (dd)PCR quantitation of HIV-1 genomes, with bioinformatics and statistical tools, we investigated differential RNA expression in frontal cortex from persons without HIV [HIV(-)], with HIV without brain disease [HIV(+)], with HAND, or HAND with encephalitis (HIVE).
Results: Expression levels for 147 transcripts and 43 miRNAs showed a minimum four-fold difference between clinical groups with a predominance of antiviral (type I interferon) signaling-related, neural cell maintenance-related, and neurodevelopmental disorder-related genes that was validated by gene ontology and molecular pathway inferences. Scale of signal-to-noise ratio (SSNR) and biweight midcorrelation (bicor) analyses identified 14 miRNAs and 45 RNA transcripts, which were highly correlated and differentially expressed ( P ≤ 0.05). Machine learning applications compared regression models predicated on HIV-1 DNA, or RNA viral quantities that disclosed miR-4683 and miR-154-5p were dominant variables associated with differential expression of host RNAs. These miRNAs were also associated with antiviral-related, cell maintenance-related, and neurodevelopmental disorder-related genes.
Conclusion: Antiviral as well as neurodevelopmental disorder-related pathways in brain were associated with HAND, based on correlated RNA transcripts and miRNAs. Integrated molecular methods with machine learning offer insights into disease mechanisms, underpinning brain-related biotypes among persons with HIV that could direct clinical care.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Competing financial interests
None of the authors have any competing financial interest.
Similar articles
-
Plasma microRNA profiling predicts HIV-associated neurocognitive disorder.AIDS. 2016 Aug 24;30(13):2021-31. doi: 10.1097/QAD.0000000000001160. AIDS. 2016. PMID: 27191977
-
A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration.BMC Genomics. 2012 Nov 28;13:677. doi: 10.1186/1471-2164-13-677. BMC Genomics. 2012. PMID: 23190615 Free PMC article.
-
MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival.FASEB J. 2010 Jun;24(6):1799-812. doi: 10.1096/fj.09-147819. Epub 2010 Jan 22. FASEB J. 2010. PMID: 20097875
-
MiRNA expression profiling in HIV pathogenesis, disease progression and response to treatment: a systematic review.Epigenomics. 2021 Oct;13(20):1653-1671. doi: 10.2217/epi-2021-0237. Epub 2021 Oct 25. Epigenomics. 2021. PMID: 34693727
-
Translating the brain transcriptome in neuroAIDS: from non-human primates to humans.J Neuroimmune Pharmacol. 2012 Jun;7(2):372-9. doi: 10.1007/s11481-012-9344-5. Epub 2012 Feb 28. J Neuroimmune Pharmacol. 2012. PMID: 22367717 Free PMC article. Review.
References
-
- van Marle G, Henry S, Todoruk T, Sullivan A, Silva C, Rourke SB, Holden J, McArthur JC, Gill MJ, Power C. 2004. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329:302–18. - PubMed
-
- Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A. 1995. Human immunodeficiency virus type 1 tat activates non-N-methyl-D- aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37:373–80. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical